Background: Refractory chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging subset of CIDP. It does not respond well to immune therapy and causes substantial disability. A ...

This systematic review demonstrated that IVIg and corticosteroids still provide the most effective first line treatment options for patients with active CIDP. The review also revealed there is a ...

The Pune region has reported 180 suspected cases of Guillain-Barre syndrome (GBS), with 146 cases confirmed and six deaths.

Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...

It refers specifically to the amount of urine excreted daily, not the frequency of bathroom trips. Polyuria is usually a symptom of other illnesses. Common causes include diabetes, kidney disease, and ...

Organic ED involves abnormalities the penile arteries, veins, or both and is the most common cause of ED, especially in older men. When the problem is arterial, it is usually caused by ...

The concept that malignant disease can cause damage to the nervous system above and beyond that caused by direct ... Patients with chronic inflammatory demyelinating polyradiculopathy (CIDP) with ...

It can cause the oesophagus to narrow ... products Hyqvia and Gammagard Liquid for chronic inflammatory demyelinating polyneuropathy (CIDP). Bain Capital has agreed to buy Mitsubishi Tanabe ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Just over a month after it was approved in the UK, AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with polyneuropathy associated with transthyretin ...